Sort   by:  
 Page size 
UnknownEfalizumab in the Treatment of Scalp, Palmoplantar and Nail Psoriasis: Results of a 24-Week Latin American Study.
Not available
S-EPMC2855826 | biostudies-literature
UnknownControl of Moderate-to-Severe Plaque Psoriasis with Efalizumab: 24-Week, Open-Label, Phase IIIb/IV Latin American Study Results.
Not available
S-EPMC2805872 | biostudies-literature
UnknownCondition-dependent effects of Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) on <i>Aspergillus fumigatus</i> growth.
Not available
S-EPMC12403852 | biostudies-literature
UnknownBenefit-risk profile of tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: pooled analysis across six clinical trials.
Not available
S-EPMC7379291 | biostudies-literature
Sort   by:  
 Page size